A clinical study to study the effect of drug VAEPPAM PATTAI KUDINEER for THANDAGA VATHAM(Lumbar Spodylosis)

A prospective open labeled randomized clinical trial on "Thandaga Vatham"(Lumbar Spondylosis) with evaluation of trial drug "Veppam Pattai Kudineer"

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012818

Enrollment

Registered

2018-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- THANDAGA VATHAM

Interventions

Intervention1: VAEPPAM PATTAI KUDINEER: 50ml BD orally for 30 days Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptoms of low back ache radiating to buttocks and lower limbs Pain aggrevated by forward bending Numbness in the lower extremities

Exclusion criteria

Exclusion criteria: Patients with Systemic Hypertension Diabetes mellitus Cardiac disease Autoimmune diseases like Rheumatoid arthritis SLE Psoriasis Congenital spinovertebral deformities Liver disease Pregnancy and lactating mother Renal diseases Tuberculosis in spine

Design outcomes

Primary

Measure	Time frame
Therapeutic efficacy of trial drug Vaeppam Pattai Kudineer for Thandaga VathamTimepoint: 30days	—

Secondary

Measure	Time frame
Evaluation of Siddha diagnostic parameters Safety of trial drug Pharmacological and Biochemical analysis of trial drugTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr T KOMALAVALLI MD PhD

GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI

komalaarumugam1@gmail.com9788122691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026